Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global veterinary anti-infectives market, 2016 2022 (USD Million)

2.2. Global veterinary anti-Infectives market: Snapshot

Chapter 3. Veterinary Anti-Infectives Market Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global veterinary anti-infectives market drivers: Impact analysis

3.2.2. Increase in pet ownership

3.2.3. Increase in zoonotic and foodborne diseases

3.2.4. Improved nutrition

3.2.5. Greater livestock production rates

3.3. Market Restraints


3.3.1. Global veterinary anti-infectives market restraints: Impact analysis

3.3.2. Increasing raw material cost

3.3.3. Stringent regulatory framework

3.3.4. Scarcity of arable land and water

3.4. Opportunities


3.4.1. Biologics and specialty care offer huge opportunities

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by species type segment

3.6.2. Market attractiveness analysis, by drug class segment

3.6.3. Market attractiveness analysis, by mode of administration segment

3.6.4. Market attractiveness analysis, by end-user segment

3.6.5. Market attractiveness analysis, by regional segment

Chapter 4. Global Veterinary Anti-Infectives Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global veterinary anti-infectives market: company market share, 2016

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Species Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development and Regional Expansion

4.3. Price Trend Analysis

Chapter 5. Global Veterinary Anti-Infectives Market Species Type Segment Analysis


5.1. Global veterinary anti-infectives market: species type overview


5.1.1. Global veterinary anti-infectives market revenue share, by species type, 2016 and 2022

5.2. Livestock


5.2.1. Global veterinary anti-infectives market for livestock market, 2016 2022 (USD Million)

5.3. Companion


5.3.1. Global veterinary anti-infectives market for companion market, 2016 2022 (USD Million)

Chapter 6. Global Veterinary Anti-Infectives Market Drug Class Segment Analysis


6.1. Global veterinary anti-infectives market: drug class overview


6.1.1. Global veterinary anti-infectives market revenue share, by drug class, 2016 and 2022

6.2. Antimicrobial Agents


6.2.1. Global veterinary anti-infectives market for antimicrobial agents market, 2016 2022 (USD Million)

6.3. Antiviral Agents


6.3.1. Global veterinary anti-infectives market for antiviral agents market, 2016 2022 (USD Million)

6.4. Antifungal Agents


6.4.1. Global veterinary anti-infectives market for antifungal agents market, 2016 2022 (USD Million)

6.5. Antiparasitic Agents


6.5.1. Global veterinary anti-infectives market for antiparasitic agents market, 2016 2022 (USD Million)

Chapter 7. Global Veterinary Anti-Infectives Market Mode of Administration Segment Analysis


7.1. Global veterinary anti-infectives market: mode of administration overview


7.1.1. Global veterinary anti-infectives market revenue share, by mode of administration class, 2016 and 2022

7.2. Oral


7.2.1. Global veterinary anti-infectives market for oral market, 2016 2022 (USD Million)

7.3. Parenteral


7.3.1. Global veterinary anti-infectives market for parenteral market, 2016 2022 (USD Million)

7.4. Topical


7.4.1. Global veterinary anti-infectives market for topical market, 2016 2022 (USD Million)

Chapter 8. Global Veterinary Anti-Infectives market End-user Segment Analysis


8.1. Global veterinary anti-infectives market: end-user overview


8.1.1. Global veterinary anti-infectives market revenue share, by end-user, 2016 and 2022

8.2. Veterinary Hospitals


8.2.1. Global veterinary anti-infectives market for veterinary hospitals 2016 2022 (USD Million)

8.3. Veterinary Clinics


8.3.1. Global veterinary anti-infectives market for veterinary clinics, 2016 2022 (USD Million)

8.4. Pharmacies


8.4.1. Global veterinary anti-infectives market for pharmacies, 2016 2022 (USD Million)

8.5. Others


8.5.1. Global veterinary anti-infectives market for others end-users, 2016 2022 (USD Million)

Chapter 9. Global Veterinary Anti-Infectives Market Regional Segment Analysis


9.1. Global veterinary anti-infectives market: regional overview


9.1.1. Global veterinary anti-infectives market revenue share, by region, 2016 and 2022

9.2. North America


9.2.1. North America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.2. North America veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.2.3. North America veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.2.4. North America veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.2.5. U.S.


9.2.5.1. U.S. veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.5.2. U.S. veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.2.5.3. U.S. veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.2.5.4. U.S. veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.2.6. Canada


9.2.6.1. Canada veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.6.2. Canada veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.6.3. Canada veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.6.4. Canada veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.2.7. Rest of North America


9.2.7.1. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.7.2. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.7.3. Rest of North America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.2.7.4. Rest of North America veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3. Europe


9.3.1. Europe veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.2. Europe veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.3. Europe veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.4. Europe veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.5. Germany


9.3.5.1. Germany veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.5.2. Germany veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.5.3. Germany veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.5.4. Germany veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.6. U.K.


9.3.6.1. U.K. veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.6.2. U.K. veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.6.3. U.K. veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.6.4. U.K. veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.7. France


9.3.7.1. France veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.7.2. France veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.7.3. France veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.7.4. France veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.8. Italy


9.3.8.1. Italy veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.8.2. Italy veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.8.3. Italy veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.8.4. Italy veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.9. Spain


9.3.9.1. Spain veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.9.2. Spain veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.9.3. Spain veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.9.4. Spain veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.10. Russia


9.3.10.1. Russia veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.10.2. Russia veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.10.3. Russia veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.10.4. Russia veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.3.11. Rest of Europe


9.3.11.1. Rest of Europe veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.3.11.2. Rest of Europe veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.3.11.3. Rest of Europe veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.3.11.4. Rest of Europe veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4. Asia Pacific


9.4.1. Asia Pacific veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.4.2. Asia Pacific veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.3. Asia Pacific veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.4. Asia Pacific veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4.5. China


9.4.5.1. China veterinary anti-infectives market revenue, by species type, 2016 2022(USD Million)

9.4.5.2. China veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.5.3. China veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.5.4. China veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4.6. Japan


9.4.6.1. Japan veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.4.6.2. Japan veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.6.3. Japan veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.6.4. Japan veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4.7. India


9.4.7.1. India veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.4.7.2. India veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.7.3. India veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.7.4. India veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4.8. Australia


9.4.8.1. Australia veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.4.8.2. Australia veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.8.3. Australia veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.8.4. Australia veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.4.9. Rest of Asia Pacific


9.4.9.1. Rest of Asia Pacific veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.4.9.2. Rest of Asia Pacific veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.4.9.3. Rest of Asia Pacific veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.4.9.4. Rest of Asia Pacific veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.5. Latin America


9.5.1. Latin America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.5.2. Latin America veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.5.3. Latin America veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.5.4. Latin America veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.5.5. Brazil


9.5.5.1. Brazil veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.5.5.2. Brazil veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.5.5.3. Brazil veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.5.5.4. Brazil veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.5.6. Mexico


9.5.6.1. Mexico veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.5.6.2. Mexico veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.5.6.3. Mexico veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.5.6.4. Mexico veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.5.7. Argentina


9.5.7.1. Argentina veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.5.7.2. Argentina veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.5.7.3. Argentina veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.5.7.4. Argentina veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.5.8. Rest of Latin America


9.5.8.1. Rest of Latin America veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.5.8.2. Rest of Latin America veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.5.8.3. Rest of Latin America veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.5.8.4. Rest of Latin America veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6. Middle East and Africa


9.6.1. Middle East and Africa veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.2. Middle East and Africa veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.3. Middle East and Africa veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.4. Middle East and Africa veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6.5. Saudi Arabia


9.6.5.1. Saudi Arabia veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.5.2. Saudi Arabia veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.5.3. Saudi Arabia veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.5.4. Saudi Arabia veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6.6. UAE


9.6.6.1. UAE veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.6.2. UAE veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.6.3. UAE veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.6.4. UAE veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6.7. Qatar


9.6.7.1. Qatar veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.7.2. Qatar veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.7.3. Qatar veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.7.4. Qatar veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6.8. South Africa


9.6.8.1. South Africa veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.8.2. South Africa veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.8.3. South Africa veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.8.4. South Africa veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)

9.6.9. Rest of Middle East and Africa


9.6.9.1. Rest of Middle East and Africa veterinary anti-infectives market revenue, by species type, 2016 2022 (USD Million)

9.6.9.2. Rest of Middle East and Africa veterinary anti-infectives market revenue, by drug class, 2016 2022 (USD Million)

9.6.9.3. Rest of Middle East and Africa veterinary anti-infectives market revenue, by mode of administration, 2016 2022 (USD Million)

9.6.9.4. Rest of Middle East and Africa veterinary anti-infectives market revenue, by end-user, 2016 2022 (USD Million)


Chapter 10. Company Profile


10.1. Bayer AG


10.1.1. Overview

10.1.2. Financials

10.1.3. Species portfolio

10.1.4. Business strategy

10.1.5. Recent developments

10.2. Dechra Pharmaceuticals Ltd.


10.2.1. Overview

10.2.2. Financials

10.2.3. Species portfolio

10.2.4. Business strategy

10.2.5. Recent developments

10.3. Neogen Corporation


10.3.1. Overview

10.3.2. Financials

10.3.3. Species portfolio

10.3.4. Business strategy

10.3.5. Recent developments

10.4. Phibro Animal Health Corporation


10.4.1. Overview

10.4.2. Financials

10.4.3. Species portfolio

10.4.4. Business strategy

10.4.5. Recent developments

10.5. Vetoquinol S.A.


10.5.1. Overview

10.5.2. Financials

10.5.3. Species portfolio

10.5.4. Business strategy

10.5.5. Recent developments

10.6. Intas Pharmaceuticals, Inc.


10.6.1. Overview

10.6.2. Financials

10.6.3. Species portfolio

10.6.4. Business strategy

10.6.5. Recent developments

10.7. Ceva Sant Animale


10.7.1. Overview

10.7.2. Financials

10.7.3. Species portfolio

10.7.4. Business strategy

10.7.5. Recent developments

10.8. Zydus Animal Health Limited


10.8.1. Overview

10.8.2. Financials

10.8.3. Species portfolio

10.8.4. Business strategy

10.8.5. Recent developments

10.9. Heska Corporation


10.9.1. Overview

10.9.2. Financials

10.9.3. Species portfolio

10.9.4. Business strategy

10.9.5. Recent developments

10.10. Cipla Limited


10.10.1. Overview

10.10.2. Financials

10.10.3. Species portfolio

10.10.4. Business strategy

10.10.5. Recent developments

10.11. Virbac S.A.


10.11.1. Overview

10.11.2. Financials

10.11.3. Species portfolio

10.11.4. Business strategy

10.11.5. Recent developments

10.12. Zoetis, Inc.


10.12.1. Overview

10.12.2. Financials

10.12.3. Species portfolio

10.12.4. Business strategy

10.12.5. Recent developments

10.13. Elanco Animal Health (Eli Lilly and Company)


10.13.1. Overview

10.13.2. Financials

10.13.3. Species portfolio

10.13.4. Business strategy

10.13.5. Recent developments